Dioleoylphosphatidylglycerol Inhibits Heat Shock Protein B4 (HSPB4)-Induced Inflammatory Pathways In Vitro
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065839 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Teresa E Fowler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: HMGB1 Protein, Toll-Like Receptor 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Our previous work shows that dioleoylphosphatidylglycerol (DOPG) accelerates corneal epithelial healing in vitro and in vivo by unknown mechanisms. Prior data demonstrate that DOPG inhibits toll-like receptor (TLR) activation and inflammation induced by microbial components (pathogen-associated molecular patterns, PAMPs) and by endogenous molecules upregulated in psoriatic skin, which act as danger-associated molecular patterns (DAMPs) to activate TLRs and promote inflammation. In the injured cornea, sterile inflammation can result from the release of the DAMP molecule, heat shock protein B4 (HSPB4), to contribute to delayed wound healing. Here, we show in vitro that DOPG inhibits TLR2 activation induced in response to HSPB4, as well as DAMPs that are elevated in diabetes, a disease that also slows corneal wound healing. Further, we show that the co-receptor, cluster of differentiation-14 (CD14), is necessary for PAMP/DAMP-induced activation of TLR2, as well as of TLR4. Finally, we simulated the high-glucose environment of diabetes to show that elevated glucose levels enhance TLR4 activation by a DAMP known to be upregulated in diabetes. Together, our results demonstrate the anti-inflammatory actions of DOPG and support further investigation into its development as a possible therapy for corneal injury, especially in diabetic patients at high risk of vision-threatening complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Department of Physiology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Charlie Norwood VA Medical Center, Augusta, GA 30904, USA.
- Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- James and Jean Culver Vision Discovery Institute, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
ORCID-Profile: Vivek Choudhary, Mitchell A Watsky, Wendy B Bollag
Förderung
- BLRD VA
- NEI NIH HHS
- National Eye Institute
- VA Merit Award
- VA Research Career Scientist Award
Zitieren
APA
Fowler, T. E., Choudhary, V., Melnyk, S., Farsi, M., Chang, L. Y., Fortingo, N., Chen, X., Watsky, M. A., & Bollag, W. B. (2023). Dioleoylphosphatidylglycerol Inhibits Heat Shock Protein B4 (HSPB4)-Induced Inflammatory Pathways In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065839
Vancouver
Fowler TE, Choudhary V, Melnyk S, Farsi M, Chang LY, Fortingo N, et al. Dioleoylphosphatidylglycerol Inhibits Heat Shock Protein B4 (HSPB4)-Induced Inflammatory Pathways In Vitro. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065839
BibTeX
@article{Fowler2023,
author = {Fowler, Teresa E and Choudhary, Vivek and Melnyk, Samuel and Farsi, Mishma and Chang, Luke Y and Fortingo, Nyemkuna and Chen, Xunsheng and Watsky, Mitchell A and Bollag, Wendy B},
title = {Dioleoylphosphatidylglycerol Inhibits Heat Shock Protein B4 (HSPB4)-Induced Inflammatory Pathways In Vitro},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065839}
}
EUVIMED